Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) had its price target upped by Westpark Capital from $24.00 to $28.00 in a research note published on Tuesday,Benzinga reports. Get Enanta Pharmaceuticals alerts:Read Our Latest Stock Report on Enanta PharmaceuticalsEnanta Pharmaceuticals Stock PerformanceEnanta Pharmaceuticals stock opened at $10.33 on Tuesday. Enanta Pharmaceuticals has a 52 week low of $4.09 and a 52 week high of $15.34. Enanta Pharmaceuticals had a negative return on equity of 89.02% and a negative net margin of 141.98%. Featured ArticlesReceive News & Ratings for Enanta Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enanta Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.